Leap Therapeutics, Inc. Share Price
LPTXLeap Therapeutics, Inc. Stock Performance
Open $0.61 | Prev. Close $2.36 | Circuit Range N/A |
Day Range $0.59 - $2.53 | Year Range $0.22 - $3.61 | Volume 37,70,512 |
Average Traded $1.49 |
Leap Therapeutics, Inc. Share Price Chart
About Leap Therapeutics, Inc.
Leap Therapeutics, Inc., a biopharmaceutical company, acquires and develops antibody therapies for the treatment of cancer. Its lead clinical stage drug candidate includes DKN-01, a monoclonal antibody that inhibits Dickkopf-related protein 1, which is in various ongoing clinical trials for treating esophagogastric and gynecologic cancers, and colorectal cancer. The company also develops FL-501, a monoclonal antibody that inhibits GDF-15 protein that is in preclinical trial. It has an option and license agreement with Adimab, LLC and BeiGene, Ltd. to develop and commercialize DKN-01 in Asia (excluding Japan), Australia, and New Zealand. The company was formerly known as HealthCare Pharmaceuticals, Inc. and changed its name to Leap Therapeutics, Inc. in November 2015. Leap Therapeutics, Inc. was incorporated in 2011 and is based in Cambridge, Massachusetts.
Leap Therapeutics, Inc. Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
12-Nov-25 | $0.60 | $2.04 | +0.00% |
12-Nov-25 | $0.60 | $2.04 | +372.29% |
11-Nov-25 | $0.42 | $0.43 | -5.66% |
10-Nov-25 | $0.47 | $0.46 | +0.44% |
07-Nov-25 | $0.41 | $0.46 | +11.74% |
06-Nov-25 | $0.40 | $0.41 | +1.24% |
04-Nov-25 | $0.41 | $0.40 | -2.65% |
FAQs on Leap Therapeutics, Inc. Share Price
Can I buy Leap Therapeutics, Inc. shares in India?
What is the share price of Leap Therapeutics, Inc.?
What is the 5 year returns of Leap Therapeutics, Inc.?
What are the high & low stock price of Leap Therapeutics, Inc. today?
What is the 52-week high and low of Leap Therapeutics, Inc. stock?